Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer

Crohn’s-like lymphoid reaction (CLR) and tumor-infiltrating lymphocytes (TILs) are crucial for the host antitumor immune response. We proposed an artificial intelligence (AI)-based model to quantify the density of TILs and CLR in immunohistochemical (IHC)-stained whole-slide images (WSIs) and furthe...

Full description

Bibliographic Details
Main Authors: Yao Xu, Shangqing Yang, Yaxi Zhu, Su Yao, Yajun Li, Huifen Ye, Yunrui Ye, Zhenhui Li, Lin Wu, Ke Zhao, Liyu Huang, Zaiyi Liu
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Computational and Structural Biotechnology Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2001037022004445
_version_ 1797978161656365056
author Yao Xu
Shangqing Yang
Yaxi Zhu
Su Yao
Yajun Li
Huifen Ye
Yunrui Ye
Zhenhui Li
Lin Wu
Ke Zhao
Liyu Huang
Zaiyi Liu
author_facet Yao Xu
Shangqing Yang
Yaxi Zhu
Su Yao
Yajun Li
Huifen Ye
Yunrui Ye
Zhenhui Li
Lin Wu
Ke Zhao
Liyu Huang
Zaiyi Liu
author_sort Yao Xu
collection DOAJ
description Crohn’s-like lymphoid reaction (CLR) and tumor-infiltrating lymphocytes (TILs) are crucial for the host antitumor immune response. We proposed an artificial intelligence (AI)-based model to quantify the density of TILs and CLR in immunohistochemical (IHC)-stained whole-slide images (WSIs) and further constructed the CLR-I (immune) score, a tissue level- and cell level-based immune factor, to predict the overall survival (OS) of patients with colorectal cancer (CRC). The TILs score and CLR score were obtained according to the related density. And the CLR-I score was calculated by summing two scores. The development (Hospital 1, N = 370) and validation (Hospital 2 &amp; 3, N = 144) cohorts were used to evaluate the prognostic value of the CLR-I score. The C-index and integrated area under the curve were used to assess the discrimination ability. A higher CLR-I score was associated with a better prognosis, which was identified by multivariable analysis in the development (hazard ratio for score 3 vs score 0 = 0.22, 95% confidence interval 0.12–0.40, P < 0.001) and validation cohort (0.21, 0.05–0.78, P = 0.020). The AI-based CLR-I score outperforms the single predictor in predicting OS which is objective and more prone to be deployed in clinical practice.
first_indexed 2024-04-11T05:18:32Z
format Article
id doaj.art-89a8b9a3393e42f0b060affdecbc095b
institution Directory Open Access Journal
issn 2001-0370
language English
last_indexed 2024-04-11T05:18:32Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Computational and Structural Biotechnology Journal
spelling doaj.art-89a8b9a3393e42f0b060affdecbc095b2022-12-24T04:54:38ZengElsevierComputational and Structural Biotechnology Journal2001-03702022-01-012055865594Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancerYao Xu0Shangqing Yang1Yaxi Zhu2Su Yao3Yajun Li4Huifen Ye5Yunrui Ye6Zhenhui Li7Lin Wu8Ke Zhao9Liyu Huang10Zaiyi Liu11Department of Radiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; School of Medicine, South China University of Technology, Guangzhou 510006, ChinaSchool of Life Science and Technology, Xidian University, Xian 710071, ChinaDepartment of Pathology, The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou 510655, ChinaDepartment of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaDepartment of Radiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou 510080, ChinaThe Second School of Clinical Medicine, Southern Medical University, Guangzhou 510080, ChinaDepartment of Radiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Department of Radiology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming 650118, ChinaDepartment of Pathology, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming 650118, ChinaDepartment of Radiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Corresponding authors at: Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou 510080, China (K. Zhao and Z. Liu). School of Life Science and Technology, Xidian University, 2 Taibai Nanlu Road, Xian, 710071, China (L. Huang).School of Life Science and Technology, Xidian University, Xian 710071, China; Corresponding authors at: Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou 510080, China (K. Zhao and Z. Liu). School of Life Science and Technology, Xidian University, 2 Taibai Nanlu Road, Xian, 710071, China (L. Huang).Department of Radiology, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China; Corresponding authors at: Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 106 Zhongshan Er Road, Guangzhou 510080, China (K. Zhao and Z. Liu). School of Life Science and Technology, Xidian University, 2 Taibai Nanlu Road, Xian, 710071, China (L. Huang).Crohn’s-like lymphoid reaction (CLR) and tumor-infiltrating lymphocytes (TILs) are crucial for the host antitumor immune response. We proposed an artificial intelligence (AI)-based model to quantify the density of TILs and CLR in immunohistochemical (IHC)-stained whole-slide images (WSIs) and further constructed the CLR-I (immune) score, a tissue level- and cell level-based immune factor, to predict the overall survival (OS) of patients with colorectal cancer (CRC). The TILs score and CLR score were obtained according to the related density. And the CLR-I score was calculated by summing two scores. The development (Hospital 1, N = 370) and validation (Hospital 2 &amp; 3, N = 144) cohorts were used to evaluate the prognostic value of the CLR-I score. The C-index and integrated area under the curve were used to assess the discrimination ability. A higher CLR-I score was associated with a better prognosis, which was identified by multivariable analysis in the development (hazard ratio for score 3 vs score 0 = 0.22, 95% confidence interval 0.12–0.40, P < 0.001) and validation cohort (0.21, 0.05–0.78, P = 0.020). The AI-based CLR-I score outperforms the single predictor in predicting OS which is objective and more prone to be deployed in clinical practice.http://www.sciencedirect.com/science/article/pii/S2001037022004445Crohn's-like lymphoid reactionTumor-infiltrating lymphocytesArtificial intelligenceColorectal cancerWhole-slide images
spellingShingle Yao Xu
Shangqing Yang
Yaxi Zhu
Su Yao
Yajun Li
Huifen Ye
Yunrui Ye
Zhenhui Li
Lin Wu
Ke Zhao
Liyu Huang
Zaiyi Liu
Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
Computational and Structural Biotechnology Journal
Crohn's-like lymphoid reaction
Tumor-infiltrating lymphocytes
Artificial intelligence
Colorectal cancer
Whole-slide images
title Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
title_full Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
title_fullStr Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
title_full_unstemmed Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
title_short Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
title_sort artificial intelligence for quantifying crohn s like lymphoid reaction and tumor infiltrating lymphocytes in colorectal cancer
topic Crohn's-like lymphoid reaction
Tumor-infiltrating lymphocytes
Artificial intelligence
Colorectal cancer
Whole-slide images
url http://www.sciencedirect.com/science/article/pii/S2001037022004445
work_keys_str_mv AT yaoxu artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT shangqingyang artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT yaxizhu artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT suyao artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT yajunli artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT huifenye artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT yunruiye artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT zhenhuili artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT linwu artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT kezhao artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT liyuhuang artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer
AT zaiyiliu artificialintelligenceforquantifyingcrohnslikelymphoidreactionandtumorinfiltratinglymphocytesincolorectalcancer